Total Payments
$45,629
2024 Payments
$36,405
Companies
7
Transactions
39
Medicare Patients
1,736
Medicare Billing
$136,012
Payment Breakdown by Category
Other$32,808 (71.9%)
Travel$10,447 (22.9%)
Food & Beverage$2,374 (5.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $21,648 | 4 | 47.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,160 | 5 | 24.5% |
| Travel and Lodging | $10,447 | 4 | 22.9% |
| Food and Beverage | $2,374 | 26 | 5.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Telix Pharmaceuticals | $22,713 | 9 | $0 (2024) |
| GE HEALTHCARE | $13,078 | 22 | $0 (2024) |
| United Imaging Healthcare North America LLC | $9,494 | 3 | $0 (2024) |
| UIH Solutions LLC | $116.41 | 2 | $0 (2023) |
| TESARO, Inc. | $94.47 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $87.23 | 1 | $0 (2023) |
| PROGENICS PHARMACEUTICALS, INC. | $46.11 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $36,405 | 12 | Telix Pharmaceuticals ($21,779) |
| 2023 | $7,547 | 13 | GE HealthCare ($6,615) |
| 2022 | $344.55 | 5 | Telix Pharmaceuticals ($154.46) |
| 2021 | $167.63 | 3 | GE HEALTHCARE ($167.63) |
| 2019 | $445.00 | 2 | GE HEALTHCARE ($445.00) |
| 2018 | $611.09 | 3 | GE Healthcare ($516.62) |
| 2017 | $108.73 | 1 | GE HEALTHCARE ($108.73) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug) | Grant | In-kind items and services | $4,920.00 | General |
| Category: PROSTATE CANCER DIAGNOSIS | ||||||
| 10/18/2024 | United Imaging Healthcare North America LLC | PET-MR (Device) | Travel and Lodging | Cash or cash equivalent | $9,384.79 | General |
| Category: Medical Imaging | ||||||
| 10/04/2024 | United Imaging Healthcare North America LLC | PET-MR (Device) | Food and Beverage | Cash or cash equivalent | $30.93 | General |
| Category: Medical Imaging | ||||||
| 10/02/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug) | Grant | In-kind items and services | $4,920.00 | General |
| Category: PROSTATE CANCER DIAGNOSIS | ||||||
| 09/04/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug) | Grant | In-kind items and services | $5,904.00 | General |
| Category: PROSTATE CANCER DIAGNOSIS | ||||||
| 08/06/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $46.11 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 07/01/2024 | United Imaging Healthcare North America LLC | PET-MR (Device) | Food and Beverage | Cash or cash equivalent | $78.55 | General |
| Category: Medical Imaging | ||||||
| 06/25/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug) | Grant | In-kind items and services | $5,904.00 | General |
| Category: PROSTATE CANCER DIAGNOSIS | ||||||
| 05/31/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $46.35 | General |
| 02/02/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $130.76 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 01/03/2024 | GE HEALTHCARE | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,320.00 | General |
| 01/03/2024 | GE HEALTHCARE | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $720.00 | General |
| 11/30/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $116.54 | General |
| 11/30/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $14.00 | General |
| 11/27/2023 | UIH Solutions LLC | — | Food and Beverage | Cash or cash equivalent | $65.00 | General |
| 09/06/2023 | GE HEALTHCARE | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,320.00 | General |
| 09/06/2023 | GE HEALTHCARE | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,440.00 | General |
| 09/06/2023 | GE HEALTHCARE | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $360.00 | General |
| 06/25/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $87.23 | General |
| 06/23/2023 | Telix Pharmaceuticals | ILLUCCIX (Drug) | Travel and Lodging | Cash or cash equivalent | $726.15 | General |
| Category: PROSTATE CANCER DIAGNOSIS | ||||||
| 06/02/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $71.86 | General |
| 03/27/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $97.39 | General |
| 03/27/2023 | GE HEALTHCARE | — | Food and Beverage | Cash or cash equivalent | $97.39 | General |
| 03/27/2023 | GE HEALTHCARE | — | Food and Beverage | Cash or cash equivalent | $97.39 | General |
| 01/26/2023 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $53.91 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 472 | 576 | $149,226 | $38,536 |
| 2022 | 10 | 485 | 578 | $168,930 | $44,467 |
| 2021 | 10 | 364 | 429 | $116,832 | $30,886 |
| 2020 | 6 | 415 | 501 | $80,058 | $22,123 |
Total Patients
1,736
Total Services
2,084
Medicare Billing
$136,012
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 115 | 119 | $42,482 | $11,087 | 26.1% |
| 79101 | Radioactive drug therapy through a vein | Office | 2023 | 52 | 84 | $24,870 | $6,628 | 26.6% |
| 78832 | Nuclear medicine study, spect imaging with concurrent ct scan, at least 2 areas or separate acquisitions, single day imaging, or single area or acquisition over multiple days | Office | 2023 | 44 | 70 | $21,542 | $5,767 | 26.8% |
| 78816 | Nuclear medicine study whole body with ct scan | Office | 2023 | 35 | 39 | $14,203 | $3,703 | 26.1% |
| 78306 | Nuclear medicine study of bone and/or joint whole body | Office | 2023 | 85 | 96 | $12,773 | $2,929 | 22.9% |
| 78812 | Nuclear medicine study from skull base to mid-thigh | Office | 2023 | 28 | 29 | $8,339 | $2,186 | 26.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $7,301 | $2,100 | 28.8% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 29 | 29 | $8,286 | $1,798 | 21.7% |
| 78835 | Quantification of radioactive materials | Office | 2023 | 44 | 70 | $4,722 | $1,272 | 26.9% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 26 | 26 | $4,710 | $1,066 | 22.6% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2022 | 133 | 145 | $53,598 | $13,914 | 26.0% |
| 78816 | Nuclear medicine study whole body with ct scan | Office | 2022 | 58 | 60 | $22,349 | $5,781 | 25.9% |
| 79101 | Radioactive drug therapy through a vein | Office | 2022 | 36 | 67 | $20,442 | $5,403 | 26.4% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2022 | 65 | 71 | $20,309 | $5,123 | 25.2% |
| 78832 | Nuclear medicine study, multiple areas with spect and concurrent ct scan | Office | 2022 | 24 | 42 | $13,392 | $3,511 | 26.2% |
| 71260 | Ct scan of chest with contrast | Office | 2022 | 66 | 70 | $12,748 | $3,205 | 25.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 19 | 19 | $8,853 | $3,002 | 33.9% |
| 78812 | Nuclear medicine study from skull base to mid-thigh | Office | 2022 | 34 | 37 | $10,885 | $2,868 | 26.3% |
| 78306 | Nuclear medicine study of bone and/or joint whole body | Office | 2022 | 27 | 27 | $3,556 | $919.67 | 25.9% |
| 78835 | Quantification of radioactive materials | Office | 2022 | 23 | 40 | $2,798 | $740.14 | 26.5% |
| 78815 | Nuclear medicine study with ct imaging skull base to mid-thigh | Office | 2021 | 96 | 103 | $37,695 | $10,144 | 26.9% |
| 78816 | Nuclear medicine study with ct imaging whole body | Office | 2021 | 47 | 52 | $19,166 | $5,033 | 26.3% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2021 | 51 | 56 | $15,730 | $4,162 | 26.5% |
| 79101 | Radioactive material therapy into vein, not radiolabeled | Office | 2021 | 22 | 49 | $14,812 | $3,991 | 26.9% |
| 71260 | Diagnostic ct scan of chest with contrast | Office | 2021 | 53 | 58 | $10,681 | $2,690 | 25.2% |
About Dr. Delphine Chen, MD
Dr. Delphine Chen, MD is a Nuclear Medicine healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740224781.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Delphine Chen, MD has received a total of $45,629 in payments from pharmaceutical and medical device companies, with $36,405 received in 2024. These payments were reported across 39 transactions from 7 companies. The most common payment nature is "Grant" ($21,648).
As a Medicare-enrolled provider, Chen has provided services to 1,736 Medicare beneficiaries, totaling 2,084 services with total Medicare billing of $136,012. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Nuclear Medicine
- Other Specialties Diagnostic Radiology
- Location Seattle, WA
- Active Since 06/16/2006
- Last Updated 04/29/2019
- Taxonomy Code 207U00000X
- Entity Type Individual
- NPI Number 1740224781
Products in Payments
- ILLUCCIX (Drug) $22,713
- PET-MR (Device) $9,494
- DISCOVERY (Device) $108.73
- ZEJULA (Drug) $94.47
- uPMR (Device) $51.41
- PYLARIFY (Drug) $46.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nuclear Medicine Doctors in Seattle
Dr. Amir Iravani Tabrizipour, Md, MD
Nuclear Medicine — Payments: $23,671
Nuclear Medicine $23,671
Dr. David Lewis, M.d, M.D
Nuclear Medicine — Payments: $392.40
Nuclear Medicine $392.40
Charles Chesnut, Md, MD
Nuclear Medicine — Payments: $197.02
Nuclear Medicine $197.02
Meena Kumar, M.d, M.D
Nuclear Medicine — Payments: $110.00
Nuclear Medicine $110.00
Dr. Murat Sadic, Md, MD
Nuclear Medicine — Payments: $53.59
Nuclear Medicine $53.59
Manuela Matesan, M.d, M.D
Nuclear Medicine — Payments: $36.54
Nuclear Medicine $36.54